Early treatment, DMARDs tied to rheumatoid arthritis remission

06/4/2013 | DailyRx.com

Patients with early rheumatoid arthritis who began treatment within the first 12 weeks of symptom onset were two times more likely to achieve remission than those who started treatment later, a study involving 1,795 patients found. The odds of achieving remission were 1.65 times higher in patients treated with disease-modifying antirheumatic drugs within the first three months of onset compared with those who started DMARD therapy later. The study was published in Annals of the Rheumatic Diseases.

View Full Article in:

DailyRx.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior director risk adjustor and coding doc
Novant Health
Charlotte, NC
Associate Director, Promotion Integrity
Bristol-Myers Squibb
Plainsboro, NJ
Vice President, Medicare Advantage
BCBS-Louisiana
Baton Rouge, LA
Chief Medical Officer
Meritus
Tempe, AZ
Director, Global Integrity and Compliance, Pharmaceuticals
Alcon
Fort Worth, TX